Safety profile of pimavanserin therapy in elderly patientswith neurodegenerative disease-related neuropsychiatric symptoms: a Phase 3b study

Authors
Category Primary study
ConferenceAlzheimer's and Dementia
Year 2023
This article has no abstract
Epistemonikos ID: 5aaab2e894756f8d4bd5e59fb6d3a73e63e51e8e
First added on: Apr 30, 2026